Biomedical applications of AMS at ANU

Conference · Fri Dec 01 00:00:00 EST 1995

OSTI ID:126698

Fifield, L K; Cresswell, R G ^[1]; Day, J P; King, S J ^[2]

---

1. Australian National Univ. (Australia)
2. Univ. of Manchester (United Kingdom)

Studies utilising {sup 26}Al have constituted the bulk of the biomedical AMS program at the ANU`s 14UD accelerator. Projects underway or completed include: the dependence on chemical form of aluminum uptake from the gut; the partitioning of Al among the various components of cells and blood; and uptake of Al by Alzheimer`s patients. In addition, capabilities for measuring {sup 32}Si, {sup 41}Ca and plutonium in a biomedical context have been established during the past year. Results of the {sup 26}Al studies and an outline of the methodology for the other isotopes will be presented and discussed.

• OSTI ID: 126698
• Report Number(s): CONF-950402-; TRN: 96:004686
• Resource Relation: Conference: 209. American Chemical Society (ACS) national meeting, Anaheim, CA (United States), 2-6 Apr 1995; Other Information: PBD: 1995; Related Information: Is Part Of 209th ACS national meeting; PB: 2088 p.
• Country of Publication: United States
• Language: English

Related Subjects

55 BIOLOGY AND MEDICINE
BASIC STUDIES
PLUTONIUM
MEASURING METHODS
ALUMINIUM 26
UPTAKE
PATIENTS
SILICON 32
CALCIUM 41
NUCLEAR MEDICINE